WINTON GROUP Ltd bought a new stake in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 6,588 shares of the company’s stock, valued at approximately $535,000.

A number of other institutional investors also recently added to or reduced their stakes in TRHC. Mount Yale Investment Advisors LLC acquired a new position in Tabula Rasa HealthCare during the 2nd quarter valued at about $111,000. Meadow Creek Investment Management LLC acquired a new stake in shares of Tabula Rasa HealthCare during the second quarter worth approximately $115,000. Envestnet Asset Management Inc. acquired a new stake in shares of Tabula Rasa HealthCare during the second quarter worth approximately $130,000. Pinebridge Investments L.P. acquired a new stake in shares of Tabula Rasa HealthCare during the second quarter worth approximately $181,000. Finally, Guggenheim Capital LLC acquired a new stake in shares of Tabula Rasa HealthCare during the first quarter worth approximately $205,000. 78.17% of the stock is currently owned by hedge funds and other institutional investors.

In other news, President Orsula V. Knowlton bought 7,500 shares of Tabula Rasa HealthCare stock in a transaction dated Monday, November 12th. The shares were bought at an average price of $65.00 per share, for a total transaction of $487,500.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $85.98, for a total transaction of $687,840.00. The disclosure for this sale can be found here. Insiders sold a total of 40,000 shares of company stock worth $3,145,120 in the last 90 days. 14.00% of the stock is owned by corporate insiders.

TRHC opened at $66.57 on Monday. Tabula Rasa HealthCare Inc has a fifty-two week low of $27.25 and a fifty-two week high of $91.16. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.46 and a current ratio of 0.49. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of -1,664.25, a price-to-earnings-growth ratio of 6.29 and a beta of 2.58.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The firm had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. During the same quarter in the previous year, the company earned $0.08 earnings per share. The business’s revenue was up 66.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Tabula Rasa HealthCare Inc will post 0.42 EPS for the current fiscal year.

Several equities analysts recently weighed in on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $99.00 price objective on shares of Tabula Rasa HealthCare in a research report on Tuesday, November 6th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research report on Saturday, August 11th. Citigroup lifted their price target on shares of Tabula Rasa HealthCare from $57.00 to $76.00 and gave the company a “buy” rating in a research report on Thursday, August 9th. Chardan Capital lifted their price target on shares of Tabula Rasa HealthCare from $77.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, November 7th. Finally, BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research report on Tuesday, November 6th. One analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $81.60.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2018/11/19/winton-group-ltd-takes-position-in-tabula-rasa-healthcare-inc-trhc.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Featured Article: Do closed-end mutual funds pay dividends?

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.